Genetics Research Identifies New Target for Alzheimer’s Disease Treatment

Professor Steve Estus discusses innovative research from his lab

14 Jan 2016
Lynsey Forsyth
Post Doc / Research Fellow

Editorial article

Prof Estus of the Sanders-Brown Center on Aging talks about Alzheimer's disease research.

Professor Steve Estus of the Sanders-Brown Center on Aging, at the University of Kentucky, is spearheading research that explores new therapeutic strategies for Alzheimer’s disease treatment. Using molecular genetics techniques that identify Alzheimer’s disease risk genes, the lab has discovered a novel target for prevention and treatment of this serious, neurodegenerative condition.

Prof Estus’s research has focused on understanding genetic risk factors that drive mechanisms underlying Alzheimer’s disease. CD33, one of the risk genes investigated by the group, shows great potential as a novel, therapeutic target for the prevention and treatment of Alzheimer’s disease. As Prof Estus says, “These genetic risk factors have been validated by nature. We know if we inhibit or impact that pathway we can impact Alzheimer’s disease, because it has already been tested by genetics.”

Understanding genetic risk


These genetic risk factors have been validated by nature. We know if we inhibit or impact that pathway we can impact Alzheimer’s disease, because it has already been tested by genetics.

Prof Steve Estus  Sanders-Brown Center on Aging


The group found that inhibition of this cell surface protein enhanced phagocytic activity of microglia, resulting in a neuroprotective effect. Ineffective phagocytosis of beta-amyloid protein is proposed as a mechanism for progression of Alzheimer’s related neurodegeneration. Antibodies against CD33 were originally trialed as a treatment for acute myeloid leukemia (AML). Although CD33 antibodies were found to be ineffective for AML treatment, they were shown to be safe, so could be repurposed for an Alzheimer’s disease trial. Preliminary work has already begun on advancing CD33 antibodies as an Alzheimer’s disease therapy, “We’ve shown that the antibodies are efficacious in vitro for knocking CD33 down and I think that this could really be a high-impact approach to reduce the risk of Alzheimer’s disease.”

The scientific strategy of the lab has been to characterize single nucleotide polymorphisms (SNPs) that are robustly associated with the risk of Alzheimer’s disease. This approach exploits the data reported in large-scale genome wide association studies and uses a high-throughput methodology to identify how SNPs modulate amino acid sequences, gene expression or alter mRNA splicing. Prof Estus’s lab have benefited from using molecular genetics techniques that incorporate TaqMan® genotyping systems with Bio-Rad Chromo4™ qPCRs, to identify and characterize risk genes, “We’ve been fortunate to use a BioRad qPCR machine, called a Chromo4. We’ve run literally thousands of samples through that machine, it has worked like a top, when it does occasionally go on the fritz, it is very quick and easy to fix and get back up running again.”

Towards Improving Alzheimer's disease outcomes

This is just one aspect of the innovative research conducted at the Sanders-Brown Center on Aging, where studies range from the microscopic level of the synapse, through animal models and right up to clinical studies. The Center supplies high quality Alzheimer’s brain tissue around the world and has a large cohort of patients available for clinical studies, as Prof Estus says, “this is one of the real strengths of the Center”. The clinical cohort comprises over 600 patients and 600 non-patient controls. In addition to clinical studies, these subjects have agreed to post-mortem brain tissue donation, making this cohort a valuable resource for Alzheimer’s research.

The continuing goal of Professor Estus, and other researchers at the Center, is to conduct ground breaking research on the risk and progression of Alzheimer’s disease risk that can contribute to improved diagnosis, treatment and outcomes for patients.

Links

Tags

AntibodiesAntibodies are used in techniques such as confocal and fluorescence microscopy, flow cytometry, ELISA, ELISPOT, immunohistochemistry, western blotting and immunopreciptation. Select specific antigen reactivity, high specific affinity, low non-specific binding, monoclonal or polyclonal, primary or secondary antibodies and associated conjugates such as an enzyme or dye for visualization.Genome AnalysisGenomics, the study of genomes, includes functional genomics, evolutionary genomics and comparative genomics. There are many genomic technologies such as DNA sequencing of whole genomes, computational biology and bioinformatics. DNA and nucleic acids must be isolated and concentrated from cells for analysis with kits, automated analyzers and software. Other useful technologies for studying genomics include PCR, microarrays and electrophoresis.High-Throughput ScreeningHigh-throughput screening (HTS) is an automated drug discovery technique for identification of active compounds against a compound library. Use HTS readers and integrated assay preparation / analysis workstations to screen your compounds. Identify active compounds against various HTS libraries, including membranes, proteins and peptides and HTS cell lines. Find the best high-throughput screening products in our peer-reviewed product directory: compare products, check customer reviews and receive pricing direct from manufacturers.PCR and Thermal CyclingPolymerase chain reaction (PCR) kits and thermal cyclers are used for the in vitro amplification of DNA permitting subsequent analysis and experimental procedures. Explore a range of high-quality polymerase, primers and nucleotides or simplify your workflow with a PCR mastermix. Find reverse transcription PCR (RT-PCR) and cDNA synthesis kits for RNA products and libraries. Quantitatively measure the amplification of DNA with real-time PCR (qPCR) and droplet digital PCR (ddPCR) kits and systems, and discover automated PCR setup solutions to increase throughput. Alternative DNA amplification methods also include recombinase polymerase amplification (RPA) kits. Find the best PCR kits and thermal cyclers and purification equipment in our peer-reviewed product directory: compare products, check customer reviews and receive pricing direct from manufacturers.SNPs TechnologySingle nucleotide polymorphisms (SNPs) are individual base variations in a DNA sequence. SNPs are used in research to study predispositions to disease and drug discovery. Products for studying single nucleotide polymorphisms include SNP arrays and detection systems to detect polymorphisms, SNP typing systems for genotyping DNA, and PCR to amplify specific SNPs.DNA / RNA Extraction and PurificationPurified DNA and RNA are required for numerous downstream molecular biology applications. Consequently, the importance of high-quality DNA/RNA extraction and purification equipment cannot be underestimated. Many purification kits are available and are typically optimized for nucleic acid type and source, including plasmid DNA, genomic DNA, mRNA, RNA and viral nucleic acid purification kits. Automated extraction and purification of nucleic acids can be implemented with magnetic bead separator instruments or high-throughput purification workstations. Find the best DNA/RNA extraction and purification equipment in our peer-reviewed product directory: compare products, check customer reviews and receive pricing direct from manufacturers.DNA SequencingDNA sequencing, such as sanger sequencing, is a biological technique that determines the precise order of nucleotide bases in a fragment or template of DNA. DNA sequencers and genetic analyzers are based on capillary electrophoresis, where labeled DNA fragments are electrophoretically separated by size as they migrate through a polymer. Find the best DNA sequencing products, including DNA sequencing kits, genomic libraries and genetic identity kits in our peer-reviewed product directory: compare products, check customer reviews and receive pricing direct from manufacturers.Next Generation SequencingNext-generation sequencing (NGS), also known as whole-genome sequencing, high-throughput sequencing and massive parallel sequencing, produces and analyses thousands to millions of nucleotide sequences at once. Sequencing systems operate via varying technologies depending on the manufacturer, including sequencing by synthesis, ligation, pyrosequencing, ion semiconductor and single-molecule real-time sequencing. For NGS, library preparation is paramount to successful sequencing. In this section, explore a range of library preparation kits, from targeted, amplicon-based or hybridization-based kits including epigenomic, transcriptomic and genomic workflows to fragmentation kits. Find the best next-generation sequencing products in our peer-reviewed product directory: compare products, check customer reviews and receive pricing direct from manufacturers.NeuroscienceNeuroscience research investigates the neurological mechanisms underlying behavior, neurodegenerative diseases, and other brain conditions. Learn about the innovative technologies for bioimaging, electrophysiology, cell culture, chromatography and other techniques used in this field.Alzheimers ResearchAlzheimer�s disease is a neurodegenerative condition characterized by progressive memory loss and cognitive decline. Research focuses on understanding the molecular and cellular mechanisms of the disease, as well as developing effective treatments and diagnostic tools. Browse our peer-reviewed product directory to find the best Alzheimer�s research products, compare options, check reviews, and get pricing directly from manufacturers.
Genetics Research Identifies New Target for Alzheimer’s Disease Treatment